Company news
Abbott India Limited (NSE:ABBOTINDIA) news
Abbott India Limited news releases on 6ix. Latest, May 12, 2026: ₹656 Dividend Bonanza: 71,000 retail shareholders of this MNC drugmaker set for their highest…
Press releases & updates
₹656 Dividend Bonanza: 71,000 retail shareholders of this MNC drugmaker set for their highest payout
May 11, 2026
ABBOTINDIA: Revenue and profit rose year-over-year, with higher dividends and an unmodified audit opinion
May 11, 2026
JPMorgan downgrades this drugmaker, cuts price target by 19% citing growth challenges
April 15, 2026
Abbott India to sell Novo Nordisk’s semaglutide, weight-loss drug behind Ozempic
February 27, 2026
ABBOTINDIA: Quarterly profit and revenue increased year-over-year, with new labour codes impacting costs
February 12, 2026
Abbott India shares decline 0.73% amid volume surge
February 10, 2026
Abbott India Receives Tax Penalty Of 24 Million Rupees
December 31, 2025
Central Government Approves Kartik Rajendran As MD of Abbott India
November 24, 2025
Buy Abbott India; target of Rs 34500: ICICI Securities
November 10, 2025
ABBOTINDIA: Strong revenue and profit growth with robust cash flows and clean audit for Q2 FY26
November 6, 2025
Abbott India share price falls 2.04% in today's trading
September 19, 2025
Buy Abbott India; target of Rs 34,470: Mirae Asset Sharekhan
September 18, 2025
Abbott India shares gain 1.21% amid volume surge
September 10, 2025
India-focused pharma firms' margins to improve from GST cuts, CLSA says
September 4, 2025
Abbott India share price falls 2.18% in today's session
August 22, 2025
Abbott India share price falls 2.35% amid bearish sentiment
August 12, 2025
ABBOTINDIA: Revenue and profit rose year-over-year, with strong EPS growth and clean auditor review
August 11, 2025
Abbott India reboots Digene: old-school antacid, new school vibe
July 30, 2025
Abbott India Shares Hit All-Time High on BSE During Today's Session
June 5, 2025
Buy Abbott India; target of Rs 35,750: ICICI Securities
May 21, 2025
Abbott India jumps on strong quarterly results
May 16, 2025
Abbott India Reports Q4 Profit Of 3.67 Billion Rupees
May 15, 2025
ABBOTINDIA: Revenue up 9.6%, PAT up 17.8%, dividend at ₹475/share, strong portfolio growth
May 14, 2025
Abbott India Says Swati Dalal Resigns As Managing Director
May 7, 2025
Abbott India Appoints Maithilee Mistry As CFO
April 18, 2025
Selloff in leading shares of drugmakers after Trump hints at tariffs on pharma imports
March 25, 2025
ABBOTINDIA: Strong revenue and profit growth with robust margins and clean audit for the latest quarter
February 4, 2025
ABBOTINDIA: Quarterly profit and revenue rose year-over-year, with robust margins and higher cash reserves
January 22, 2025
Investors lose Rs 3.7 lakh crore as US Fed outlook, FII selling among top factors behind market sell-off
December 19, 2024
ABBOTINDIA: Quarterly profit and revenue increased year-over-year, with strong cash and no audit concerns
November 6, 2024
Trade Spotlight: How should you trade Abbott India, NALCO, ITC, Vishnu Chemicals, Power Grid, and others on Tuesday?
November 4, 2024
Buy Abbott India; target of Rs 32000: Sharekhan
August 12, 2024
ABBOTINDIA: Q1 FY25 saw strong revenue and profit growth, with EPS up 13% year-over-year
August 6, 2024
Buy Abott India; target of Rs 32,500: ICICI Securities
May 16, 2024
Buy Abbott India; target of Rs 30,540: Sharekhan
May 15, 2024
Abbott India shares surge 5% on strong Q4 results, record dividend payout
May 10, 2024
Abbott Q4 Results: Net profit rises 24% to Rs 287 crore, revenue up 7%
May 9, 2024
New buy signal generated in these 4 F&0 scrips as per RMI scanner
March 29, 2024
Abbott India scale 52-week high after solid Q3 earnings
February 2, 2024
Buy Abbott India; target of Rs 26,723 Sharekhan
November 13, 2023